Abstract: A method for processing an X-ray computed tomography (CT) image using a neural network and an apparatus therefor are provided. An image reconstruction method includes receiving low-dose X-ray CT data, obtaining an initial reconstruction image for the received low-dose X-ray CT data using a predetermined analytic algorithm, and reconstructing a denoised final image using the obtained initial reconstruction image and a previously trained neural network.

Abstract: A method for processing an X-ray computed tomography (CT) image using a neural network and an apparatus therefor are provided. An image reconstruction method includes receiving low-dose X-ray CT data, obtaining an initial reconstruction image for the received low-dose X-ray CT data using a predetermined analytic algorithm, and reconstructing a denoised final image using the obtained initial reconstruction image and a previously trained neural network.

Abstract: Disclosed is a method of reconstructing an image. The method of reconstructing an image includes receiving low dose X-ray computed tomography (CT) data, applying an analytic principle to an optimization approach for low dose imaging to transform the low dose X-ray CT data, and removing a noise included in the low dose X-ray CT data to reconstruct a high-quality image.

Abstract: Disclosed is a method of reconstructing an image. The method of reconstructing an image includes receiving low dose X-ray computed tomography (CT) data, applying an analytic principle to an optimization approach for low dose imaging to transform the low dose X-ray CT data, and removing a noise included in the low dose X-ray CT data to reconstruct a high-quality image.

Abstract: The described invention relates to novel human immunodeficiency virus protease inhibitors, pharmaceutical compositions containing at least one such inhibitor, methods of preparing such inhibitors, and methods of utilizing such inhibitors to treat HIV and HIV-related disorders.

Abstract: The present invention relates to a composition for treating obesity-related diseases comprising an insulinotropic peptide conjugate, more particularly, to a composition for treating obesity-related diseases comprising a conjugate prepared by covalently linking the insulinotropic peptide with a carrier substance via a non-peptidyl linker, and a method for treating obesity-related diseases by using the same. In particular, the composition for treating obesity-related diseases according to the present invention remarkably improves the efficacy of suppressing food intake and its duration to reduce body weight and body fat, thereby being useful for the treatment of obesity-related diseases.

Abstract: The described invention relates to novel human immunodeficiency virus protease inhibitors, pharmaceutical compositions containing at least one such inhibitor, methods of preparing such inhibitors, and methods of utilizing such inhibitors to treat HIV and HIV-related disorders.

Abstract: The present invention relates to a composition for treating obesity-related diseases comprising an insulinotropic peptide conjugate, more particularly, to a composition for treating obesity-related diseases comprising a conjugate prepared by covalently linking the insulinotropic peptide with a carrier substance via a non-peptidyl linker, and a method for treating obesity-related diseases by using the same. In particular, the composition for treating obesity-related diseases according to the present invention remarkably improves the efficacy of suppressing food intake and its duration to reduce body weight and body fat, thereby being useful for the treatment of obesity-related diseases.